FI
CHRS icon

Fosun International’s Coherus Oncology CHRS Stock Holding History

Fosun International’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-238,248
Closed -$5.12M – 251
2019
Q2 		$5.12M Buy
238,248
+46,000
+24% +$799K 0.34% 45
2019
Q1 		$2.64M Buy
192,248
+126,748
+194% +$1.69M 0.17% 82
2018
Q4 		$576K Buy
+65,500
New +$758K 0.03% 200

Other funds holding CHRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fosun International's CHRS Position: Q3 2019 in Review

Fosun International sold out of Coherus Oncology (CHRS) in Q3 2019, closing a stake of 238,248 shares — an estimated $5.12M sold.

Fosun International first reported a position in CHRS in Q4 2018 and held it in 3 quarters. The position peaked at $5.12M in Q2 2019. 167 funds tracked by Wall St. Rank hold CHRS as of Q3 2019.

  • Fosun International reported no remaining Coherus Oncology position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 238,248 Coherus Oncology shares in Q3 2019, an estimated $5.12M.
  • Fosun International first reported a position in Coherus Oncology in Q4 2018 and held it in 3 quarters.
  • Fosun International's Coherus Oncology position peaked at $5.12M in Q2 2019.
  • 167 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.